Vox Markets fund manager interview with Christopher Mills
In this Xmas Special, 1st class fund manager Christopher Mills of Harwood Capital takes me through:
00:00 His outlook for equities next year
03:35 Pendragon and surge in M&A.
13:25 Spire Healthcare
17:20 NIOX
22:30 EKF Diagnostics.
26:50 Renalytix & Verici Dx
31:00 Animalcare
35:00 Avingtrans
39:50 Centaur Media
41:40 Hostmore
44:25 Redcentric
49:05 Maintel
51:25 Restore
54:20 TP ICAP
57:30 Assetco
59:10 Polar Capital
61:30 Flowtech Fluidpower
66:00 Carr’s Group
68:00 MJ Gleeson & UK housebuilders
72:20 Frenkel Topping
78:50 What to avoid in 2024
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.